See All Services
In Quebec, where one in four adults is obese, the current cost of these new drugs (approximately $500 per month) would involve an annual expenditure of several hundred million dollars (in the United States the situation is even worse: the cost of a 72-week course of tirzepatide (15 mg/week) is approximately US$17,000, while the 68-week treatment with semaglutide (2.4 mg/week) is nearly US$23,000!)
Neuromolecular etiology of bipolar disorder: possible therapeutic targets of mood stabilizers
The starting dose may vary depending on factors such as age, the medical condition being treated, severity of symptoms, and response to therapy
The drug, developed by the Danish company Novo Nordisk, can be used for weight loss if prescribed by a doctor for off-label use
A study of patients taking phentermine-topiramate lost 20 to 32 pounds over about a year, depending on the dose